年龄对接受初级皮肤冠状动脉干预的STEMI患者手术前TIMI流量的影响
Monica Verdoia1, Rocco Gioscia1, Orazio Viola1
1Division of Cardiology, Ospedale degli Infermi, ASL Biella, Biella.
Journal of cardiovascular medicine (Hagerstown, Md.)
|August 22, 2023
概括
高龄是一个独立的预测者,在接受初级皮肤冠状动脉干预 (pPCI) 的ST段升高心肌梗塞 (STEMI) 患者中,更好地预测了与手术前心脏病相关的动脉通透率. 进一步的研究将探索对程序结果和长期预后的影响.
科学领域:
- 心脏病学 心脏病学
- 老年医学 老年医学
- 干预心脏病学 干预心脏病学
背景情况:
- 高龄是影响ST段升高心肌梗塞 (STEMI) 患者预后的重要因素.
- 在老年STEMI患者中,低于最佳的再输和增加并发症背后的机制尚不清楚.
- 这项研究研究了年龄对血管学发现和初级皮肤穿冠状动脉干预 (pPCI) 程序结果的影响.
研究的目的:
- 评估慢性年龄对STEMI患者血管检查结果的影响.
- 评估年龄对初级穿皮冠状动脉干预 (pPCI) 成功的影响.
- 为了确定年龄是否影响干预前心脏病相关动脉 (IRA) 穿透性.
主要方法:
- 分析了一组520名接受pPCI治疗的STEMI患者.
- 患者被分为年龄分层:<61,61-72岁,≥73岁.
- 与心脏病相关的动脉 (IRA) 穿透性被定义为手术前的TIMI流量3.
主要成果:
- 老年患者 (≥73岁) 与年轻人群相比,IRA通透率 (41.1%) 的发病率更高.
- 高龄独立地与程序前IRA通透率的增加有关 (调整后OR为0.68;P=0.04).
- 年龄与血栓和狭窄率相反相关,但与静止率相对正相关.
结论:
- 在接受pPCI的STEMI患者中,晚年是程序前IRA通透性的独立预测因素.
- 这些发现表明,年龄会影响STEMI的早期再输.
- 需要进一步的研究来澄清与年龄相关的透性在STEMI管理中的长期预后影响.
更多相关视频
04:48Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery
Published on: November 28, 2018
8.0K
05:07Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice
Published on: August 25, 2023
1.1K
相关概念视频
01:30Acute Coronary Syndrome I: Introduction
30
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
30
01:28Cardiac Catheterization I: Pre-Procedure Overview
57
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
57
01:28Acute Coronary Syndrome IV: Interprofessional Care
12
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
12